Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Progyny Inc (NASDAQ: PGNY) closed at $22.05 up 0.87% from its previous closing price of $21.86. In other words, the price has increased by $0.87 from its previous closing price. On the day, 1.49 million shares were traded. PGNY stock price reached its highest trading level at $22.32 during the session, while it also had its lowest trading level at $21.92.
Ratios:
For a deeper understanding of Progyny Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.84. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 2.80. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On November 13, 2024, Truist Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $19.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 26 ’24 when Schlanger David J bought 150,000 shares for $14.68 per share. The transaction valued at 2,202,330 led to the insider holds 228,269 shares of the business.
Anevski Peter bought 209,500 shares of PGNY for $3,034,084 on Dec 23 ’24. The CHIEF EXECUTIVE OFFICER now owns 441,463 shares after completing the transaction at $14.48 per share. On Dec 09 ’24, another insider, SEIDENBERG BETH C, who serves as the Director of the company, bought 39,680 shares for $15.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 1883363072 and an Enterprise Value of 1674680832. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 39.01, and their Forward P/E ratio for the next fiscal year is 26.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.61 while its Price-to-Book (P/B) ratio in mrq is 4.46. Its current Enterprise Value per Revenue stands at 1.435 whereas that against EBITDA is 23.711.
Stock Price History:
The Beta on a monthly basis for PGNY is 1.35, which has changed by -0.4046976 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, PGNY has reached a high of $38.98, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is 0.80%, while the 200-Day Moving Average is calculated to be 5.66%.
Shares Statistics:
For the past three months, PGNY has traded an average of 1.95M shares per day and 1950710 over the past ten days. A total of 85.31M shares are outstanding, with a floating share count of 71.37M. Insiders hold about 16.44% of the company’s shares, while institutions hold 89.95% stake in the company. Shares short for PGNY as of 1740700800 were 11371537 with a Short Ratio of 5.84, compared to 1738281600 on 11470131. Therefore, it implies a Short% of Shares Outstanding of 11371537 and a Short% of Float of 16.870001000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
